- Home
- LYEL vs KEQU Comparison
LYEL vs KEQU Comparison
Compare LYEL & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- KEQU
- Stock Information
- Founded
- LYEL 2018
- KEQU 1906
- Country
- LYEL United States
- KEQU United States
- Employees
- LYEL N/A
- KEQU N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- KEQU Medical Specialities
- Sector
- LYEL Health Care
- KEQU Industrials
- Exchange
- LYEL Nasdaq
- KEQU Nasdaq
- Market Cap
- LYEL 207.7M
- KEQU 174.3M
- IPO Year
- LYEL 2021
- KEQU N/A
- Fundamental
- Price
- LYEL $11.02
- KEQU $55.22
- Analyst Decision
- LYEL Sell
- KEQU
- Analyst Count
- LYEL 2
- KEQU 0
- Target Price
- LYEL $15.00
- KEQU N/A
- AVG Volume (30 Days)
- LYEL 72.8K
- KEQU 10.1K
- Earning Date
- LYEL 08-11-2025
- KEQU 09-10-2025
- Dividend Yield
- LYEL N/A
- KEQU N/A
- EPS Growth
- LYEL N/A
- KEQU N/A
- EPS
- LYEL N/A
- KEQU 3.83
- Revenue
- LYEL $65,000.00
- KEQU $240,472,000.00
- Revenue This Year
- LYEL N/A
- KEQU N/A
- Revenue Next Year
- LYEL N/A
- KEQU N/A
- P/E Ratio
- LYEL N/A
- KEQU $14.45
- Revenue Growth
- LYEL N/A
- KEQU 18.02
- 52 Week Low
- LYEL $7.65
- KEQU $30.33
- 52 Week High
- LYEL $32.60
- KEQU $71.33
- Technical
- Relative Strength Index (RSI)
- LYEL 52.37
- KEQU 51.86
- Support Level
- LYEL $9.11
- KEQU $53.00
- Resistance Level
- LYEL $14.18
- KEQU $59.54
- Average True Range (ATR)
- LYEL 0.94
- KEQU 2.17
- MACD
- LYEL 0.15
- KEQU -1.02
- Stochastic Oscillator
- LYEL 38.68
- KEQU 33.94
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About KEQU Kewaunee Scientific Corporation
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.